Graf Acquisition Corp. IV (GFOR) Closes NKGen Biotech Deal
by Nicholas Alan Clayton on 2023-10-02 at 9:18am

Graf Acquisition Corp. IV (NYSE:GFOR) has closed its combination with NKGen Biotech and its shares and warrants will begin trading on the Nasdaq under the symbols “NKGN” and “NKGNW” today.

The SPAC secured shareholder approval for the deal last week with 84.3% redemptions. Graf IV CEO James Graf is set to join the combined company as its interim CFO.

The $160 million combination was initially announced in April of this year. Santa Ana, California-based NKGen has five pharmaceutical formulas that have each reached some stage of Phase I and Phase II clinical trials seeking potential therapies for cancer and neurodegenerative conditions like Parkinson’s and Alzheimer’s.

The company expects to release interim data from its Phase I trials for drug candidate SNK-02 for solid tumor treatments before the end of 2023.


ADVISORS

  • Company
    • Cooley LLP is acting as legal advisor to NKGen and NKMax.
  • Sponsor
    • White & Case LLP is acting as legal advisor to Graf.
Recent Posts
by Nicholas Alan Clayton on 2024-07-17 at 8:40am

The use of forward projections by target companies going through a SPAC transaction has been a controversial topic since the SPAC boom began in 2020. But, left to the side of this issue has been the question, “Do de-SPACs even benefit from using projections?” Certainly plenty of de-SPACs have taken hits in the public markets...

by Nicholas Alan Clayton on 2024-07-17 at 8:28am

At the SPAC of Dawn Futures are starting the day deep red after hitting a string of highs this month, but many of the corners of the market populated by de-SPACs appear to have more room to roll. Small-caps overall are having a strong month as the Russell 2000 has surged forward nearly +11% over...

by Nicholas Alan Clayton on 2024-07-16 at 8:08am

At the SPAC of Dawn As the US elections draw nearer, more intersections of SPACs and politics are likely to continue to emerge. One day further into the Republican National Convention and Trump Media (NASDAQ:DJT) is now facing a slight -9% regression in the aftermarket, while conservative social media platform Rumble (NASDAQ:RUM) experienced its own...

by Nicholas Alan Clayton on 2024-07-15 at 3:53pm

Bleichroeder Acquisition Corp I (NASDAQ:BACQU) has filed to be the second SPAC brought to market by Santander in 2024, aiming to raise $250 million without the help of anchor investors. Many of Bleichroeder I’s terms are familiar in the current market with its trust initially funded to 100.0% with $10.00 in its units to start...

by Nicholas Alan Clayton on 2024-07-15 at 10:54am

Aquaron (NASDAQ:AQU) has entered into a definitive agreement to combine with hydrogen technology firm HUTURE at an initial equity value of about $1 billion. Shanghai-based HUTURE has developed technology for hydrogen fuel cell-powered heavy trucks and the refilling stations that would supply them. The combined company is expected to trade on the Nasdaq once the...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved